Author: Tom Smith
-
UK Competition and Market Authority’s consultation on merger remedies confirms greater flexibility
The CMA’s consultation on its revised merger remedies guidance, published on 16 October 2025, confirms a more flexible approach to remedies including in Phase 1 – a trend already seen in recent CMA decisions.
-
Illumina/Grail: An unholy war continues
The European Commission has blocked a merger that did not meet any European jurisdictional thresholds for the first time. In a case that has seen the Commission pushing at the boundaries of its remit, it has prohibited Illumina’s $8 billion acquisition of GRAIL. Article 22 EUMR The Illumina/GRAIL merger did not meet the thresholds under…